Global Newcastle Disease Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Newcastle Disease Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Newcastle disease is an acute, hot, septic and highly contagious infectious disease of poultry caused by Newcastle disease virus. It is characterized by high fever, dyspnea, diarrhea, nervous disorder and bleeding of mucous membrane and serosa. Besides affecting chickens and Duck & Goose, it can also spread in other birds. In addition, it has been found in sheep.

Newcastle disease vaccine can effectively improve the incidence and situation of the epidemic. However, many Newcastle disease vaccines will deteriorate after being stored at room temperature for one or two hours. This makes them unsuitable for villages that may need to transport vaccines for hours or even days at ambient temperature.

Market Overview:

The latest research study on the global Newcastle Disease Vaccine market finds that the global Newcastle Disease Vaccine market reached a value of USD 297.32 million in 2022. It’s expected that the market will achieve USD 367.31 million by 2028, exhibiting a CAGR of 3.59% during the forecast period.

The industrial chain is affected

The influence of pneumonia epidemic in COVID-19 on Newcastle disease vaccine industry involves all the main links and entities in the industrial chain. Under the epidemic situation, the management efficiency of the company declined, commuting was severely hindered, the production plan was seriously hindered, the network expansion and marketing were delayed, the brand was forced to adjust, and the income of the company and employees was damaged.

SMEs face challenges

The pneumonia epidemic situation in COVID-19 has greatly affected the global Newcastle disease vaccine industry, especially the after-sales operation of small and medium-sized enterprises. Stopping production not only aggravates the shortage of funds for small and medium-sized enterprises, but also reduces the solvency of enterprises, which may affect production and sales. Some enterprises have difficulties in operation and even go bankrupt. The epidemic has seriously affected logistics and transportation. The industrial chain of SMEs is imperfect and fragile.

The production cost of enterprises increases

With the gradual control of the epidemic, some factories began to resume production. However, enterprises need to protect the life and health of employees in the production process, such as buying masks, disinfectants and other epidemic prevention materials, disinfecting the working environment before and after production, and testing the body temperature of employees every day to ensure their health. These measures will increase production costs and affect the development of enterprises.

Newcastle disease is harmful

Newcastle disease is an infectious virus bird disease, which affects many poultry and wild birds and can be transmitted to human beings. Symptoms of poultry diseases vary with virus type, poultry type, poultry health and age, and environmental conditions. Chicken is the most susceptible group, and the virus strain can spread rapidly in the affected chicken group, and the strong virus strain can destroy the whole chicken group; Attenuated strains only cause respiratory tract infection and egg production decline in chickens, but they can recover quickly. Infected birds may show symptoms such as green diarrhea, dyspnea, sudden death, loss of wings, loss of appetite and lethargy, etc. The strain causes severe respiratory distress and nervous problems, leading to high morbidity and high mortality, and nervous system symptoms include tremor, torticollis (twisted neck) and paralysis. In addition, the prevalence of Newcastle disease in sheep was also found. Humans can also cause conjunctivitis or lymphadenitis due to contact with sick birds and live vaccines, but recover quickly. On the whole, Newcastle disease may lead to destructive loss of business. Therefore, Newcastle disease vaccine is necessary for farms with chickens, ducks and geese.

High temperature affects vaccine effect Vaccines are known to deteriorate within a few hours at room temperature, so they are not suitable for transportation to distant villages. In addition, in hot season, immunization time should be conducted in the morning, avoiding high temperature time to prevent the effect from being affected. This factor may inhibit market growth.

Awareness of breeders' diseases

Vaccination is affected by human subjective factors. If livestock keepers don't know enough about this disease, they may not be vaccinated, which will have a negative impact on market growth.

Region Overview:

North America dominated the Newcastle Disease Vaccine market in 2022, with a market share of 23.21%.

Company Overview:

Boehringer Ingelheim is one of the major players operating in the Newcastle Disease Vaccine market, holding a share of 20.23% in 2023.

Boehringer Ingelheim

Boehringer Ingelheim, a research-driven pharmaceutical company, is a global group of companies whose goal is to improve the health and quality of life of humans and animals. The company focuses on developing innovative therapies that can prolong patients' lives. In animal health, Boehringer Ingelheim represents advanced preventive measures.

Merck Animal Health

Merck Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services. Offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

Segmentation Overview:

Among different product types, Killed Vaccines segment is anticipated to contribute the largest market share in 2028.

Live Vaccines

Live vaccines replicate in the host causing a mild or undetected disease and bring about an immune response which mimics natural infection.

Killed Vaccines

To produce this type of vaccine, bacteria or viruses are killed or inactivated by a chemical treatment or heat. Inactivated vaccines are suitable for healthy individuals, as well as people with weakened immune systems as they do not contain live forms of the microorganism which they are designed to protect against. Inactivated vaccines do not always create a strong or long-lasting immune response, in the same way as live vaccines, so they usually require repeated doses or booster doses.

Application Overview:

By application, the Chicken segment occupied the biggest share from 2018 to 2022.

Chicken

Chickens are susceptible to many infectious diseases, the most important of which is a viral disease called Newcastle disease. Newcastle disease vaccine: it is divided into inactivated vaccine and live vaccine. The live vaccine mainly includes line I, line II (B1 strain), line III (F strain), line IV (Lasota strain), clone -30 and so on. The first strain is a moderately virulent vaccine, which can cause symptoms and even death to chickens, but can quickly produce strong immunity, and is mostly used for chickens over 2 months old or emergency vaccination.

Duck & Goose

Newcastle disease is a highly infectious epidemic, which can spread in Duck & Goose. Vaccination against Newcastle disease can prevent and cure the disease.

Key Companies in the global Newcastle Disease Vaccine market covered in Chapter 3:

Hester Biosciences Limited
Harbin Veterinary Research Institute
CEVA
Zoetis
Yebio
Merck Animal Health
QYH Biotech Co.
CAVAC
Ringpu Biology
Boehringer Ingelheim
Kyoto Biken
Phibro Animal Health Corporation
FATRO
Elanco
JAPFA
ChengDu Tecbond
DHN

In Chapter 4 and Chapter 14.2, on the basis of types, the Newcastle Disease Vaccine market from 2018 to 2029 is primarily split into:

Live Vaccines
Killed Vaccines

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Newcastle Disease Vaccine market from 2018 to 2029 covers:

Chicken
Duck & Goose
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)